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Abstract.  a-Factor, one of the mating pheromones of 
Saccharomyces  cerevisiae,  binds specifically to a 
receptor on the plasma membrane of a  cells,  is inter- 
nalized and delivered to the vacuole, where it is 
degraded. At  15°C the rate of pheromone uptake is 
only slightly affected while delivery to the vacuole is 
markedly slowed down. A  transport intermediate car- 
rying a-factor to the vacuole can be reversibly trapped 
by treatment with the metabolic inhibitors,  NaN3  and 
NaE  This intermediate(s) is distinct from the vacuole 
and the plasma membrane as judged by differential 
and density gradient centrifugation analysis. We pres- 
ent evidence that the a-factor is protected from pro- 
tease digestion by a detergent-sensitive structure,  sug- 
gesting that the pheromone resides within a  vesicular 
compartment. We propose that this intermediate(s) 
represents an endocytic or prevacuolar compartment(s) 
involved in vesicular traffic from the plasma mem- 
brane to the vacuole. 
T 
HE budding yeast Saccharomyces cerevisiae is a uni- 
cellular organism that requires the action of peptide 
pheromones for the conjugation of haploid a  and a 
cells (Hartwell, 1973; Sprague et al.,  1983; Kurjan, 1985). 
a cells respond to a-factor pheromone that is secreted by a 
ceils; a  cells respond to a-factor pheromone secreted by a 
cells. The reciprocal action of these two diffusable peptide 
hormones mediates a series of events that culminate in the 
production  offa/a  diploid  cells:  transcription  of several 
genes  is  induced (Hagen and Sprague,  1984;  Stetler and 
Thorner,  1984) and mating-specific cell surface agglutinins 
are produced (Fehrenbacher et al., 1978). Cell growth is ar- 
rested in the Gt  phase of the cell cycle (Hartwell,  1973), 
and cell and nuclear fusion are coordinated (Trueheart et al., 
1987; McCaffrey et al.,  1987; Rose et ai.,  1986).  An addi- 
tional response to the mating factors includes the induction 
of a morphological change, called the "shmoo" It is charac- 
terized by a local elongation of the yeast cell, providing the 
fusion site during zygote formation (reviewed by Thorner, 
1981; and Sprague et al.,  1983), 
Signals to initiate the mating program in yeast are trans- 
duced through distinct cell surface receptors,  specific for 
each mating factor. The a-factor receptor, encoded by the 
STE2 gene (Jenness et al., 1983, 1986; Blumer et al., 1988), 
is  a  431  residue polypeptide that contains seven  putative 
membrane-spanning  domains  (Burkholder  and  Hartwell, 
1985;  Nakayama et al.,  1985).  This topological motif is 
shared by the a-factor receptor (encoded by the STE3 gene), 
although there is no apparent sequence homology between 
the  two  proteins  (Nakayama et  al.,  1985).  Jenness  and 
Spatrick (1986) provided evidence that the a-factor receptor 
is subject to downregulation. This event is accompanied by 
internalization of a-factor. Independently, Chvatchko et al. 
(1986) demonstrated that the pheromone is internalized by 
a cells in a time-, temperature-, and energy-dependent fash- 
ion and furthermore that it is degraded, most likely in the 
vacuole (Chvatchko,  1987; Dulid, 1989). These findings led 
to the hypothesis that a-factor is internalized by receptor- 
mediated endocytosis. In mammalian cells several polypep- 
tide hormones like insulin and epidermal growth factor are 
taken  up  by  receptor-mediated  endocytosis  via  clathrin 
coated pits (Carpenter and Cohen, 1976; Gavin et al., 1974). 
The/~-adrenergic receptor, which has a striking structural 
similarity to the a-factor receptor,  has also been demon- 
strated to be sequestered, although the pathway of this inter- 
nalization is less understood (Sibley and Lefkowitz, 1985). 
In this study we have followed the uptake and degradation 
of  35S-a-factor  to  investigate  the  endocytic  pathway  in 
yeast. This system has the advantage of being physiologically 
relevant in contrast to systems using nonphysiological mark- 
ers  (Riezman,  1985;  Makarow,  1985a  b;  Makarow  and 
Nevalaineh,  1987).  Although downregulation of receptor 
sites and transport of the pheromone presumably to the vacu- 
ole are consistent with the hypothesis of receptor-mediated 
endocytosis, a  direct demonstration of a  vesicular uptake 
mechanism is clearly desirable. To facilitate the demonstra- 
tion and isolation of a  potential vesicular intermediate in- 
volved in a-factor uptake and transport, we have made use 
of a low temperature incubation and metabolic inhibitors. 
These manipulations have been used successfully in mam- 
malian c'ells to block transport  from endosomes to  lyso- 
somes (Dunn et al.,  1980;  Marsh et al.,  1983;  Griffiths et 
©  The Rockefeller University Press, 0021-9525/90/06/1911/12 $2.00 
The Journal of Cell Biology, Volume 110, June 1990  1911-1922  1911 al., 1988; Davey et al., 1985; Gruenberg and Howell, 1986). 
We show that transport of o~-factor to the vacuole, where 
degradation most likely takes place, is significantly slowed 
down at a low temperature and can be further blocked in the 
presence of metabolic inhibitors. Applying these conditions, 
we can trap t~-factor  within a  membrane-sealed compart- 
ment(s)  that  is  distinct from the  vacuole and  the plasma 
membrane.  Therefore, we provide the first evidence for a 
membranous intermediate compartment(s) containing t~-fac- 
tor, a hallmark of endocytosis. 
Materials and Methods 
Strains, Media, and Reagents 
The strains of S.  cerevisiae  used in these experiments were RH144-3D 
(Mata, his4, leu2, ura3,  barl-l) and RH732 (Mata, his4, leu2, ura3, lys2, 
bad-I, pep4::URA3). This strain was derived from RH448 (Mata, his4, 
leu2,  ura3,  lys2, barl-l) by a one-step gene disruption using the plasmid 
pTS15 (kindly provided by T. Stevens, University of Oregon, Eugene, OR). 
RH449 (Mata, his4, leu2, ura3, lys2, barl-1) was used for a-factor produc- 
tion. All yeast strains were grown in complete medium (2% yeast extract, 
2% peptone [both Gibco Ltd., Paisley, Great Britain], 40/zg/ml each ade- 
nine [Sigma Chemical Co., St. Louis, MO] and uracil [E. Merck, Darm- 
stadt, Federal Republic of Germanyl, and 2 % glucose) to exponential phase 
(2  x  l07 cells/ml) at 30°C on a  rotary shaker.  Lyticase was prepared as 
described by Scott and Schekman (1980).  35S-sulfate (43 Ci/mg) was ob- 
tained from Du Pont de Nemours International S. A. (Regensdorf, Switzer- 
land). Proteinase K was from Merck and BSA was from Sigma Chemical 
Co. Silica gel 60 plates (analytical and preparative) were purchased from 
Merck, and solvents were either from Fluka AG (Buchs, Switzerland) or 
Merck.  Nycodenz was obtained from Nyegaard Co.  (Oslo, Norway) and 
BCA  protein assay  reagent  from  Pierce Chemical  Co.  (Rockford,  IL). 
Chemicals for SDS-PAGE were purchased from Bio-Rad (Richmond, CA), 
nitrocellulose filters were from Millipore Continental Water Systems (Bed- 
ford, MA), and Ponceau S was obtained from Serva (Heidelberg, FRG). 
ENTENSIFY and EN3HANCE spray were from Du Pont de Nemours In- 
ternational  S.  A.  NaN3  was purchased from Merck and  NaF  was from 
Sigma Chemical  Co.  Buffers, Triton  X-100,  and  quinacrine  were from 
Sigma Chemical Co. DEAE-dextran was obtained from Pharmacia (Upp- 
sala, Sweden) and Amberlite ion exchange resin, type CG-50 (mesh size 
100-200)  was from Serva. 
Production of  ~S-t~-Factor 
~S-labeled u-factor was synthesized and isolated as previously described 
by Duli~ and Riezman (1989).  In brief, RH449 cells were transformed with 
the plasmid pDA6300 (kindly provided by J. Thorner, University of Califor- 
nia, Berkeley,  CA), a 2-# based plasmid containing tbe MFcd,  STEI3, and 
LEU2 genes. Transformants, showing at  least  10-fold overproduction of 
a-factor (monitored by halo assay) were used for biosynthetic labeling and 
a-factor was prepared from the culture supernatant by chromatography on 
CG-50  (Jenness et  al.,  1983).  Fractions containing biologically active 
a-factor, as determined by either halo assay or shmoo assay, were pooled, 
dried, and further purified using HPLC (p. BONDAPAK  TM C18 column, 300 
×  3.9 mm ID,  10-#m particle size; Millipore). a-Factor was eluted under 
isocratic conditions with 29.6%  acetonitrile, 0.025%  trifluoroacetic acid. 
Fractions were analyzed by TLC using the solvent system butanol/propionic 
acid/water (100:50:70,  vol/vol/vol) with chemically synthesized a-factor as 
a  standard on silica gel  60 plates.  Purified 35S-ct-factor  was dried and 
resuspended in 0.01 N HCI, 1 mM DTT, 0.2 mM EDTA and stored in small 
aliquots  in liquid nitrogen.  The specific radioactivity  of 35S-a-factor  ranged 
from 5 to  10 Ci/mmol of active pheromone. 
s-Factor Uptake and Degradation Assays 
Pheromone internalization and degradation assays were carried out as de- 
scribed by Duli6 and Riezman (1989).  Uptake assays were performed at 5, 
10, 15, 19, or 30°C, using the strains RH144-3D and RH732. When a-factor 
degradation was analyzed in the presence of metabolic poisons, NaN3 and 
NaF were added to 20 mM each (final concentration) after allowing uptake 
for various times at  15°C as indicated in the figures. At the same time the 
cells were transferred to a 30°C waterbath. The radioactivity was extracted 
from cells and resolved by TLC after different times of internalization as 
indicated in the figures. To analyze the reversibility of the NaN3 and NaF 
treatment, cells were incubated for 15 min at  15°C,  NaN3 and NaF were 
added, and the cells were shifted to 30°C. After 15 min the cells were har- 
vested and resuspended in inhibitor-free medium, and uptake was continued 
at 300C.  When bafilomycin A~  (kind gift of K. Altendorf, University of 
Osnabrfick, Osnabriick, Germany) was used, a 6.6 mM stock was prepared 
in DMSO, and the drug (or DMSO alone) was added to 10 #M final concen- 
tration after allowing uptake to occur for 15 min at 15°C. Lower concentra- 
tions of bafilomycin Ai were not effective in elevating vacuolar pH, as de- 
termined by quinacrine staining (see below). Upon addition of the drug the 
temperature was raised to 30"C.  10, 45, and 105 min after the addition of 
bafilomycin Ai cells were stained with quinacrine as described by Banta et 
al.  (1988)  and immediately viewed by epifluorescence using a  Zeiss Ax- 
iophot microscope. Intact and degraded a-factor were resolved by TLC 
(using preparative 2.2  mm silica-gel 60 plates) as described above, and 
fluorographs on preflashed films (Kodak XAR-5) were quantified by den- 
sitometric scanning on a computing densitometer (Molecular Dynamics, 
Sunnyvale, CA). 
Cell Fractionation 
For each fractionation experiment using differential centrifugation analysis 
,°5 ×  109 RH732 cells were harvested from an exponentially growing cul- 
ture, resuspended in complete medium to 1 x  109 cells/ml, and chilled on 
ice. 35S-a-factor (6  x  105 cpm) was added and allowed to bind for i h on 
ice. The cells were resuspended in the same volume of ice-cold, 15 or 30°C 
complete medium and were further incubated for 30, 20, or 30 min, respec- 
tively.  After this incubation the cells were diluted ,010-fold  with ice-cold 
sorbitol medium (0.6 M sorbitol, 5 mM 2-amino-2methyl-l,3-propanediole- 
Pipes, pH 6.8) and harvested. The cells were washed with ice-cold sorbitol 
medium, resuspended in 20 ml of 0.14 M cysteamine-HCI, 0.6 M sorbitol, 
25  mM 2-amino-2methyl-l,3-propanediole-Pipes, pH 6.8,  5  mM EDTA, 
5 mM NAN3, and 5 mM NaF and were incubated at 30°C for 20 min. Af- 
ter this pretreatment, the cells were diluted with ice-cold sorbitol medium, 
pelleted, and resuspended in 1 ml sorbitol medium, containing 5 mM NaN3 
and 5 mM NaF and "01  ×  104 U lyticase. The cells were converted into 
spheroplasts at 30°C for 1 h and centrifuged at  1,500 g at 4°C through a 
0.6 M sucrose cushion,  containing 5 mM 2-amino-2-methyl-l,3-pmpanediole- 
Pipes, pH 6.8. The pellet was resuspended with 4.5 ml ice-cold sorbitol 
medium and the spheroplasts were lysed by adding 90-135 #1 of 10 mg/ml 
DEAE-dextran (in sorbitol medium) at 0°C and then warming up to 30°C 
for 5-7 min. The lysate was subjected to three successive centrifugation 
steps at 4"C. First, it was centrifuged at 3,500 g  for 5 min, resulting in PI 
and SI. The supernatant SI was centrifuged at 10,000 g for 10 min (giving 
rise to P2 and $2). Finally the supernatant $2 was subjected to centrifuga- 
tion at 100,000 g resulting in P3 and $3. The three pellets (P1, P2, and P3) 
were resuspended in ice-cold sorbitol medium and aliquots of each of the 
six fractions were counted for 35S-a-factor or were TCA precipitated and 
resuspended in SDS gel sample buffer (50 mM Tris, pH 6.8, 2.5 mM EDTA, 
2% [wt/vol] SDS, 5% [wt/vol] glycerol, 0.01% [wt/vol] bromphenol blue, 
and 2.5 % lvol/vol] 2-mercaptoethanol). Two samples from each fraction 
('020 and 40 #g protein) were resolved on 7.5% polyacrylamide gels con- 
taining 8 M urea using the buffer system of Laemmli (1970).  After elec- 
trophoresis, proteins were transferred to  nitrocellulose, as described by 
Towbin et al. (1979). After transfer, the nitrocellulose filter was stained with 
Ponceau S and incubated for 1 h with blocking buffer (2.5%  [wt/vol] dry 
fat milk, 0.2% [wt/voll Triton X-100 in PBS). The filters were either treated 
with antiserum against the plasma membrane H+-ATPase  (kindly provided 
by N.  Nelson, Roche Institute of Molecular Biology,  Nutley,  NJ,  diluted 
1:2,000),  against carboxypeptidase Y  (CPY) I (diluted  1:500)  or against 
hexokinase (kindly provided by G. Schatz, Biocenter, Basel, Switzerland; 
diluted 1:i,000).  Incubation with the antiserum was carried out for 1 h with 
shaking at  room temperature.  The filters were  washed four times with 
blocking buffer.  After washing, the filters were incubated with 1-2 #Ci of 
~2Sl-protein A in blocking buffer for 1 h as described before. After air dry- 
ing, the filters were subjected to fluorography at  -70°C using intensifying 
screens. Fluorographs on preflashed films (Kodak XAR-5) were quantified 
by densitometric scanning on a TLC scanner (type II; Camag, Muttenz, 
Switzerland). Since the extent of cell lysis varied between individual experi- 
ments, it was necessary to correct the individual values for cell lysis in order 
to be able to compare the various conditions and different experiments. The 
1. Abbreviation  used in this paper:  CPY, carboxypeptidase Y. 
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plasmic hexokinase after centrifugation at 3,500 g. From localization stud- 
ies  of hexokinase by  immunocytochemistry (van  Tuinen  and  Riezman, 
1987),  we calculated that "°95% of the total cellular hexokinase is in the 
cytoplasm and 5% is in nuclei. Although these 5% should pellet at 3,500 g 
when 100%  of the cells are lysed, we neglected this small fraction in our 
calculations and considered the amount of hexokinase found in PI to origi- 
nate from unlysed cells. The fraction of unlysed cells was calculated as fol- 
lows:  fraction of unlysed cells  =  Plhexokinase/(Plhexokina~e +  Slhexokinase). 
The average lysis in 18 experiments was 63 +  2 ! %. The amount of  the other 
markers found in PI was corrected for cell lysis by the following formula: 
PI  =  Plunc,,rrccted  -  (fraction of unlysed cells)  ×  (Pluncorrected 4- Sl). The 
total was obtained by addition of PI  and SI. 
For subfractionation on density gradients •5  ×  10 t° cells and 1.5-2.5 
×  106 cpm 35S-~t-factor were used as the starting material. Uptake of 35S- 
ct-factor was carried out for 20 min at 15 °C and the P3 fraction was obtained 
as described before except that the second differential centrifugation step 
was carried out at 7,500  g  for 5 rain in order to optimize the recovery of 
a-factor in the P3 pellet. This fraction was resuspended in 1.1 ml of 35% 
(wt/vol) Nycodenz (Nycodenz stock solution) and homogenized five times 
using a  I-ml tissue grinder (Wheaton Industries, Millville, NJ).  The ho- 
mogenate was transferred to a  13.2-ml  centrifuge tube (Ultra-Clear; Beck- 
man Instruments Inc., Palo Alto, CA) and a discontinuous gradient was pre- 
pared by overlaying 1 ml of homogenate with 2.5 ml each of 31, 27, 20, and 
13%  Nycodenz solution. These solutions were dilutions of the Nycodenz 
stock solution with sorbitol medium (so that the decreasing Nycodenz con- 
centrations were accompanied by an increase in sorbitol and buffer concen- 
tration). The gradient was subjected to centrifugation at 4°C for 14-16  h 
at  100,000  g  in a TST41.14  swinging bucket rotor (Kontron Instruments, 
Ziirich, Switzerland). A total of 17 fractions (each "-,650 ~1) were collected 
from the top of the gradient by pumping 60% (wt/vol) sucrose into the bot- 
tom of  the tube. A major part of  the pellet formed during centrifugation was 
not collected. This probably explains why only 40% of the protein loaded 
onto the gradient was recovered. However, >95%  of 35S-a-factor  was re- 
covered. Aliquots from each fraction were analyzed for 35S-a-factor and 
H+-ATPase  as described before. Protein concentration was assayed by the 
BCA  procedure described in  a  company  brochure by  the manufacturer 
(Pierce Chemical Co.).  The density of the fractions was determined by 
measuring the refractive index and reading the corresponding density from 
a standard curve. The standard curve was obtained from a mock gradient 
by determining the refractive index and the density of each fraction. 
Table L tl/2  for a-Factor  Uptake and a-Factor 
Degradation as a Function of Temperature 
Temperature  t:_  uptake  t:. degradation 
°C  mm  min 
30  3.75  10 
19  6.75  23 
15  7.5  53 
10  23  >120 
35S-a-factor uptake and degradation  experiments  were performed as described 
in the legends to Fig.  1 and Fig. 3. The t,2 for pheromone uptake was calcu- 
lated from the initial  rate of uptake  for the curves shown in Fig.  1.  The t:. 
for a-factor degradation  (disappearance  of intact,  internalized  or-factor) was 
calculated  in the following  way.  The amount  of internalized,  intact a-factor 
(pH  1.2 samples)  was determined by densitometric  scanning  of fluorographs 
as shown in Fig. 3. After an initial increase in intact, internalizaed a-factor the 
data  gave  a  linear  decay  curve on a  logarithmic  scale.  The t:_  is  the time 
necessary  to degrade 50% of the remaining intact u-factor. The values given 
for 30 and 15°C are the means of three experiments, the tt~2 for degradation 
at  19°C was calculated  from two experiments, and at  10°C from one experi- 
ment.  The radioactivity  from the internalized,  intact c~-factor is generally  re- 
covered in the degradation  products. 
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Figure 1.  Effect of temperature on a-factor uptake, a cells (RH144- 
3D)  were incubated with 35S-a-factor (1  x  105 cpm/109 cells) for 
1 h  at 0°C as described in Materials and Methods. The cells were 
harvested  and  resuspended  in  prewarmed,  glucose-containing, 
potassium phosphate buffer. Uptake was done at 5  (~),  10 (o),  15 
(a),  19 (A), and 30°C (D). At the indicated times duplicates of 10  s 
cells  were  washed  with  pH  1.2  buffer to  determine  internalized 
a-factor and with pH 6 buffer to determine cell-associated a-factor. 
After filtering the cells, the associated radioactivity was determined 
by liquid scintillation counting. Uptake is expressed as the ratio be- 
tween  internalized  and  total  cell-bound  radioactivity  (total  cell- 
bound radioactivity ranged from 5,500 to 8,500 cpm). The values 
obtained at 30,  19,  15, and 10°C are an average of at least three ex- 
perimetits.  Uptake at 5°C was done once. 
Figure 2.  a-Factor degradation is PEP4 dependent. Wild-type (wt) 
cells (RH144-3D) and isogenic pep4 cells (RH732) were incubated 
with  asS-a-factor (2  x  105  cpm/109  cells)  for  1  h  at  0°C.  After 
removal of unbound pheromone the cells were resuspended in 30°C 
prewarmed,  glucose-containing, potassium  phosphate buffer and 
incubated at 30°C.  At the indicated times aliquots were treated at 
pH  1.2 or 6  and the radioactivity was extracted from the cells as 
described in Materials and Methods. The extract was loaded on sil- 
ica plates and resolved by TLC. The radioactivity originating from 
pH  1.2- or 6-treated cells is indicated by labeling the lanes  I  and 
6,  respectively.  The  positions of the  intact  (i)  and  degraded  (d) 
a-factor are indicated. The intact a-factor consists of the authentic 
pheromone (Rr =  0.27)  and most likely the methionine sulfoxide 
form of the native pheromone (Rf  =  0.21)  (Raths,  S.,  Biocenter, 
Basel,  personal  communication).  The fluorograms were exposed 
for 7  d  at  -70°C. 
Singer and Riezman Intermediate in ct-Factor  Traffic to  Vacuole  1913 Figure 3. Effect of temperature  on a-factor degradation.  35S-a-factor was incubated with RH144-3D cells for 1 h on ice. The cells were 
harvested,  resuspended in 10,  15,  19, or 30°C prewarmed,  glucose-containing,  potassium phosphate buffer and incubated for up to 2 h 
at the indicated temperature.  Samples were treated at pH 1.2 (1) and pH 6 (6) at the indicated times and extracts were resolved by TLC 
as described  in Materials and Methods. The positions of the intact (i) and the degraded  (d) a-factor are shown. The fluorograms were 
exposed between 6 and 8 d at  -70°C. 
Protease Protection 
The 100,000 g pellet (P3), that was obtained as described before with the 
second differential centrifugation at 10,000 g for 10 min, was resuspended 
in 90 #1 0.6 M sorbitol, 50 mM Tris, pH 8,  1 mM CaClz (sorbitol buffer), 
and divided into three aliquots. Two aliquots were incubated with 0.5 mg/ml 
proteinase K either in the presence or in the absence of 0.5 % Triton X-100 
for 15 min at 30°C. A control aliquot was incubated without any additions. 
After cooling on ice, PMSF was added to  1 mM final concentration, and 
the samples were denatured by adding 40 #1 of 3 x  SDS gel sample buffer 
and heating for 5 min at 95°C. The samples were resolved by SDS-PAGE 
on 17.5% polyacrylamide gels. The gels were fixed, treated with ENTEN- 
S|FY, dried, and subjected to fluorography at  -70°C. Fluorographs were 
scanned as described above, Time courses of protease protection using 0.2 
and 0.5 mg/ml proteinase K were also performed as described above taking 
samples after  15- and 30-rain digestion at 30°C. 
Results 
Effect of Temperature on a-Factor Uptake 
In mammalian cells low temperature incubations have been 
successfully applied to arrest delivery of endocytosed mole- 
cules to lysosomes. We therefore explored the effect of low 
temperature on  a-factor uptake and  degradation  with  the 
hope of finding conditions that would trap a-factor on its way 
to the vacuole. For these studies 35S-a-factor was bound to 
a  cells at 0°C for 1 h,  unbound a-factor was washed away, 
and  the  cells  were  resuspended  in  prewarrned,  glucose- 
containing, potassium-phosphate buffer at 5,  10,  15,  19, or 
30°C. At various times aliquots were removed and treated at 
pH 6 or 1.2. The pH 6 treatment gives a measure of the total 
cell-associated radioactivity, whereas at pH  1.2 the surface 
bound radioactivity is removed and the internalized a-factor 
can be measured. In Fig.  1 the fraction of bound c~-factor that 
is internalized is expressed as a function of time at the indi- 
cated temperatures. At 30°C pheromone uptake is the most 
rapid and complete by 30 min (Fig.  1); the time required to 
internalize 50% of the bound a-factor is 4 min (Table I). At 
15 and  19°C the initial rate of uptake is reduced by factors 
of 1.8 and 2, respectively (Table I). This is only weakly im- 
paired compared with 10°C, where pheromone uptake is re- 
duced by a factor of 6. Only at 5°C, however, is a-factor in- 
ternalization  nearly blocked.  During the first 5  min of the 
incubation at 15,  19, and 30°C, ,'020% of the surface-bound 
a-factor dissociates from the cells. This, however, does not 
affect the internalization rates calculated, because these cal- 
culations  take into account both the  internalized  and total 
a-factor at every time point. 
a-Factor Degradation in pep4 and Wild-type Cells as a 
Function of Temperature 
Degradation of pheromone has been shown to be dependent 
on the PEP4  gene product, proteinase A (Chvatchko,  1987; 
Duli6,  1989), that is responsible for activating many soluble 
vacuolar hydrolases (Ammerer et al.,  1986; Woolford et al., 
1986).  Here we examine the kinetics of a-factor degradation 
in  wild-type  and pep4 cells.  In  wild-type cells  the  intact 
pheromone  that  is  internalized  by the  cells  is  completely 
degraded by 30 min (Fig. 2). Different degradation products 
appear successively between 15 and 45 min. Although pep4 
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a-fact6r at 30°C. RHI44-3D cells were incubated with 3~S-~-factor 
on ice for 1 h. After pheromone binding, cells were harvested and 
resuspended  in  15°C prewarmed,  glucose-containing,  potassium 
phosphate buffer. After allowing uptake for 15 min at 15°C, NaN3 
and NaF were added (each 20 mM final concentration) and the ceils 
were transferred to a 30°C waterbath. At the indicated times sam- 
ples were analyzed by extracting the radioactivity from the cells and 
resolving  the  products  by TLC.  The position  of intact  (i)  and 
degraded  (d)  pheromone  originating  from pH  1.2- (1)  and  pH 
6- (6) treated cells is indicated. The fluorograms were exposed for 
7 d at -70°C. The quantitation  of this experiment  is presented in 
Fig. 5 B. 
cells  internalize  a-factor  as  efficiently  as  wild-type  cells 
(data not shown), the majority of the pheromone remains in- 
tact for at least 120 min (Fig. 2, bottom). This suggests that 
the  vacuole  is  the  site  of a-factor degradation.  Upon  ex- 
tended incubation (90 min and more) a new species migrat- 
ing  just  below  the  intact  a-factor  appears  and  a  minor 
amount of degradation products can be seen. The accumula- 
tion of the first mentioned species, that cannot be observed 
in wild-type cells, might be due to an extremely low level 
of vacuolar hydrolase activity. Alternatively, the lack of en- 
zymes that are responsible for rapid degradation under nor- 
mal conditions could allow another nonphysiological modifi- 
cation to occur. 
Assuming that the vacuole is the site of degradation,  we 
used or-factor degradation as a  marker for delivery of the 
pheromone  to  the  vacuole.  Since  a-factor uptake  is  only 
moderately reduced at 19 and 15°C,  it was of interest to see 
what  effect these  temperatures  have  on  degradation.  The 
results  are presented  in  Fig.  3.  Lowering the  temperature 
reduces the rate of a-factor degradation. The time necessary 
to degrade 50% of the internalized, intact a-factor is shown 
in Table I. At 19°C the degradation and uptake rates are re- 
duced to a similar extent. However, at 15 and 10°C degrada- 
tion is more severely affected than uptake. In both cases the 
effect of temperature on degradation is two fold greater than 
on  uptake (Table I).  This finding  can be explained in  two 
ways. First, a step in the a-factor degradation pathway subse- 
quent to uptake may be more temperature sensitive than up- 
take.  This step could be a  vesicular transport step from a 
prevacuolar compartment to the vacuole. Alternatively, one 
could argue that the primary reason for the delay in a-factor 
degradation is not a transport problem, but simply due to re- 
duced  vacuolar hydrolase activity at low temperature. 
Degradation of a-Factor Can Be Blocked by 
Metabolic lnhibitors 
To demonstrate that the reduced rate of a-factor degradation 
at 15°C is not solely due to reduced vacuolar hydrolase activ- 
ity at this low temperature, we tested whether a-factor that 
has been internalized at  15°C can be degraded in the pres- 
ence of metabolic inhibitors at 30°C. If  the pheromone is al- 
ready  transported  to  the  vacuole  at  15°C,  it  should  be 
degraded at 30°C,  even in the presence of NaN3  and NaE 
since ATP is not required for the enzymatic activity of vacuo- 
lar hydrolases. After allowing uptake for 15 rain at 15°C, the 
metabolic poisons were each added to a final concentration 
of 20 mM and the cells were transferred to a 30°C waterbath. 
Upon shift to 30°C, in the absence of NaN3 and NaE a-fac- 
tor is degraded, demonstrating that the effect of temperature 
is reversible (Fig. 4). However, in the presence of metabolic 
inhibitors degradation is completely inhibited (Fig. 4). The 
same degree of inhibition can be achieved using 5 mM each 
NaN3  and  NaF  (data  not  shown).  The argument could be 
made that a raised vacuolar pH, due to the presence of the 
metabolic inhibitors,  might be the primary reason for the 
block in a-factor degradation seen in the NAN3- and NaF- 
treated cells. To exclude this possibility we investigated a-fac- 
tor degradation in cells that had been treated with the specific 
and potent inhibitor of the vacuolar H÷-ATPase, bafilomy- 
cin A, (Bowman et al.,  1988).  To confirm that the drug ac- 
tually raises the vacuolar pH under the applied conditions, 
cells were stained with quinacrine, a fluorescent dye that ac- 
cumulates in acidified organelles (Weisman et al.,  1987).  10, 
45,  and  105 min after the addition of bafilomycin A~ the cells 
did not show any staining with quinacrine while control cells 
did  (data  not  shown),  demonstrating that the vacuolar pH 
was raised by the drug. This is in agreement with the results 
described by Banta et al. (1988), and also confirms that the 
inhibitor is active over the whole time course of the experi- 
ment. Addition  of DMSO alone has almost no inhibitory effect 
on a-factor degradation, and treatment with bafiiomycin A~ 
delays but does not block degradation (Fig. 5 A). Quantita- 
tion of the internalized,  intact a-factor (Fig. 5 B, open and 
solid circles) reveals that  bafilomycin A:treated  cells ex- 
hibit an immediate delay in degradation upon addition of the 
Singer and Riezman Intermediate in c~-Factor  Traffic to Vacuole  1915 Figure 5. Bafilomycin  A~ does not block oe-factor  degradation. (A) The experiment was done as described in Fig. 4. Instead of NaN~ and 
NaF, bafilomycin AI was added to 10-#M final concentration where indicated. Control cells (top) were treated with DMSO alone. (B) 
The amount of intact a-factor (i) that is extracted from the pH 1.2 treated cell samples was quantified by densitometric scanning of the 
fluorographs shown in A and Fig. 4 (see Materials and Methods) and is expressed as a function of time. The values obtained from the 
experiment described in A are symbolized by the open and solid circles. The values obtained from the experiment described in Fig. 4 
are symbolized by the open and solid squares. (<2) +  bafilomycin; (o)  -  bafiiomycin; (l)  +  NAN,, +  NaF; (t2)  -  NAN,, -  NaE 
drug. This is noticed from the superaccumulation of inter- 
nalized,  intact a-factor. After ~30 min the intact a-factor 
starts to disappear with perhaps slightly reduced kinetics in 
comparison to control cells.  Fig. 5 B also presents the quan- 
titation of intact a-factor in the NAN3- and NaF-treated and 
untreated cells, shown in Fig. 4.  The respective values are 
symbolized by the open and solid squares (Fig.  5 B), and 
clearly demonstrate that the metabolic inhibitors exert a quali- 
tatively and quantitatively different  effect on a-factor degra- 
dation than bafilomycin A~.  These results  support the idea 
that the lack of pheromone degradation, observed in the pres- 
ence of metabolic poisons, is not solely due to vacuolar pH 
but is more likely due to a block in transport from an endo- 
cytic, prevacuolar compartment to the vacuole. 
To determine  the  kinetics of delivery of a-factor to the 
vacuole at 15°C, cells were incubated  with prebound a-factor 
for various periods at 15°C before they were shifted to 30°C 
for an additional incubation in the presence of metabolic in- 
hibitors. Extracts of cells were analyzed after a total incuba- 
tion time of 120 min.  This experiment shows that the cells 
can be left for at least 30 min at 15°C without detecting any 
a-factor degradation (Fig. 6). Only at or after 45 min at 15°C 
can one detect the appearance of degradation products. After 
any time period at  15°C  the additional incubation at 30°C 
in the presence of NaN~ and NaF results  in very little  fur- 
ther degradation of a-factor (compare with Fig. 3). This sug- 
gests that a-factor degradation is not limiting  at 15°C in the 
absence of metabolic inhibitors.  The a-factor must be very 
rapidly degraded upon delivery to the vacuole.  Moreover, 
these experiments suggest that from  15 to 30 min at  15°C, 
when most of  the a-factor is internalized, there is no delivery 
of pheromone to the vacuole. 
Inhibition of a-Factor Degradation in NAN3- and 
NaF-treated Cells Is Reversible 
Since the preceding results  imply that a combination of low 
temperature  and  NaN3 and  NaF treatment can result  in  a 
block  in  transport  of a-factor  to  the  vacuole,  we  asked 
whether this block is reversible,  a-Factor was internalized at 
15°C  for 15 min and the cells were transferred to 30°C in 
the presence of NaN3 and NaE  After a  15-min  incubation 
to impose the block, the cells were harvested, resuspended 
The Journal of Cell Biology, Volume  110, 1990  1916 Figure 6.  Addition of metabolic  inhibitors  after various times of 
a-factor internalization.  RHI44-3D cells were incubated with 35S- 
a-factor for 1 h on ice. After pheromone binding the cells were har- 
vested and resuspended  in  15°C prewarmed,  glucose-containing, 
potassium phosphate buffer at time zero. At the indicated times ali- 
quots of cells were shifted to 30°C and NaN3 and NaF were added 
(a control sample was incubated in the absence of metabolic poi- 
sons IP]). After a total  incubation time of 120 min (including up- 
take at 15°C and further incubation at 30°C) the state of the a-fac- 
tor was analyzed by extracting the radioactivity and resolving the 
products by TLC. The fluorograms were exposed for 7 d at -70°C. 
The position  of intact  (i) and degraded  (d) a-factor originating 
from pH 1.2- (1) and pH 6-(6) treated cells  is indicated. 
in inhibitor-free medium, and further incubated at 30°C. As 
shown in Fig. 7, 30 min after removal of NaN3 and NaF the 
a-factor is almost completely degraded. Only a minor frac- 
tion of the intact species is not degraded.  This finding sug- 
gests  that  the  majority  of  the  undegraded  a-factor,  ac- 
cumulating in  the  NaNr and NaF-treated cells,  is trapped 
on the transport pathway to the vacuole (see below) and can 
be subsequently chased through it upon removal of the meta- 
bolic inhibitors. 
Sedimentation Behavior of a-Factor After Uptake at 
Different Temperatures 
To  confirm  the  idea  that  pheromone  transport  from  the 
plasma membrane to the vacuole passes through a prevacuo- 
lar compartment, we analyzed the sedimentation behavior of 
a-factor after different uptake regimes and compared it with 
a  vacuolar,  a  plasma  membrane,  and  a  cytosolic  protein 
marker.  The  pheromone  was  either  bound  to  the  plasma 
membrane at 0°C or was allowed to be internalized at 30°C 
for 30 rain or at 15°C for 20 min. We hypothesized that a-fac- 
tor internalized at 30°C for 30 min would cofractionate with 
a vacuolar marker, as under these conditions it is completely 
degraded,  whereas  when  uptake  is  performed at  15°C  it 
would not fractionate with the vacuole. For these experiments 
pep4 cells were used to avoid nonspecific protein and a-fac- 
tor degradation during the fractionation.  After pheromone 
uptake,  the cells were converted into spheroplasts at 30°C 
in the presence of 5 mM of both NaN3 and NaF, to inhibit 
further pheromone transport. Cells were broken using poly- 
base-induced lysis with DEAE-dextran as described by Dtirr 
et al. 0975). This gentle lysis procedure is especially advan- 
tageous to analyze fragile organelles.  The lysate was sub- 
jected to three successive centrifugation steps. First,  it was 
centrifuged at 3,500 g  for 5 min, giving a low speed pellet 
PI and a low speed supernatant S1. This supernatant was cen- 
trifuged at 10,000 g for 10 min, resulting in P2 and $2. The 
$2 was finally subjected to 100,000 g for 1 h, giving rise to 
P3  and  $3.  The  distribution  of a-factor and  three protein 
markers in the six fractions was quantified by counting the 
radioactivity of 35S-a-factor and  by  Western  blotting,  re- 
spectively. Plasma membrane was detected using an antise- 
rum against the plasma membrane H÷-ATPase, and the dis- 
tribution of the vacuole was followed by an antiserum against 
CPY. To correct for the varying extent of cell lysis we addi- 
tionally quantified the distribution of the cytoplasmic marker 
hexokinase (as described  in  Materials  and Methods).  The 
distribution of the described markers in the six fractions is 
presented  in  Fig.  8.  The  plasma membrane H÷-ATPase is 
found most prevalently, and under all conditions (0,  15, and 
30°C),  in P1  (50-60%).  The remaining amount is found in 
approximately equal  quantities  in  P2  and P3.  The soluble 
vacuolar marker, CPY, sediments under all conditions pre- 
dominately at 3,500 g.  This demonstrates that most of the 
vacuoles remain intact under the described lysis conditions. 
Most of the  remaining CPY  ("~15%)  is  found in  the high 
speed supernatant $3,  whereas in P2 and P3 only very little 
can be detected.  To rule out that the incubation of cells in 
the presence of metabolic poisons might influence or change 
the distribution of these two markers, spheroplasts were pre- 
pared in the absence of NaN3 and NaF, lysed, and fraction- 
ated as described before. As expected,  we obtained results 
similar to those described above (data not shown), implying 
that treatment with NaN3  and NaF does not alter the sedi- 
mentation behavior of CPY and the plasma membrane H ÷- 
ATPase. Whereas the distribution of the vacuolar and plasma 
membrane markers do not change with the various condi- 
tions, the distribution of 3sS-a-factor does. After incubation 
at 0°C the radioactivity cofractionates with the plasma mem- 
brane H÷-ATPase. When  the  pheromone is  internalized  at 
30°C,  its sedimentation behavior is similar to that of CPY, 
providing further evidence that a-factor is transported to the 
vacuole, where degradation takes place. Interestingly, when 
a-factor uptake is done  at  15°C,  the  pheromone does not 
Figure 7. The block in u-factor degradation due to NaN3 and NaF 
is  reversible.  Binding and  uptake  of 35S-a-factor in  RH144-3D 
cells was done as described  in the legend to Fig. 4.  15 min after 
the  addition  of 20 mM  of both  NaN3 and  NaF and the  shift to 
30°C, the ceils were harvested and resuspended in the same volume 
of inhibitor-free medium and further incubated at 30°C. The radio- 
activity was extracted at the indicated time points. The position of 
intact (i) and degraded (d) pheromone is marked. The fluorogram 
was exposed for 8 d at  -70°C. 
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Figure 8.  Sedimentation  be- 
havior  of  CPY,  the  plasma 
membrane  H÷-ATPase, and 
u-factor after pheromone bind- 
ing at 0°C and  uptake  at  15 
and  30°C.  RH732 cells  were 
incubated  with  35S-(x-factor 
for  1 h  at  0°C  in  complete 
medium. The cells were either 
left at 0°C for 30 min, or were 
warmed  up  to  15°C  for  20 
min,  or to 30°C for 30 min. 
The cells were converted  into 
spheroplasts in the presence of 
5 mM each NaN3 and NaF as 
described  in  Materials  and 
Methods.  The  spheroplasts 
were  centrifuged  through  a 
0.6-M sucrose cushion, resus- 
pended  in  sorbitol  medium, 
and lysed as described in Ma- 
terials and Methods. The lysate 
was centrifuged  at 3,500 g for 
5 min, resulting in PI and Si. 
SI was centrifuged at 10,000 g 
for 10 min,  giving rise to P2 
and $2; $2 was finally subject- 
ed to  100,000 g  for 60 min, 
resulting in P3 and $3. Aliquots 
from each of the six fractions 
were counted for 35S-tx-factor and proteins were resolved by SDS-PAGE. Vacuolar CPY, the plasma membrane H÷-ATPase, and cytoplas- 
mic hexokinase  were detected  by Western blot analysis  and quantified  by densitometric scanning  (see Materials  and Methods).  The in- 
dividual values for each marker were corrected for cell lysis as described in Materials  and Methods.  The error bars represent the standard 
deviation  of the mean of at least five experiments  at every condition,  n.d., not detectable. 
fractionate  like  CPY  nor  like  the  plasma  membrane  H ÷- 
ATPase. The largest fraction sediments at  100,000 g  (35 % 
in P3) and the remaining amount is found almost equally in 
P1,  P2,  and  $3.  This  result  clearly  demonstrates  that  the 
a-factor taken up at 15°C is not associated with the vacuole 
nor with the plasma membrane, but may be trapped within 
an intermediate  compartment(s)  (see below).  The fact that 
this compartment sediments at  100,000 g  is consistent with 
it being a  small organelle. 
a-Factor That Is Sedimentable at lO0,O00 g Is 
Membrane Enclosed 
To determine whether the pheromone found in the 100,000 g 
pellet (P3) resides within a membrane-sealed compartment, 
we investigated its sensitivity to protease digestion. Aliquots 
from the P3 fraction were either left untreated or incubated 
with proteinase K in the presence or absence of Triton X-100. 
The reaction products were separated on 17.5 % SDS-poly- 
acrylamide gels that were analyzed by fluorography and den- 
sitometry. By using 0.5 mg/ml proteinase K in the presence 
of Triton X-100 (Fig. 9, lane 2), all of the a-factor is degraded 
after a  15-min incubation,  while 66%  of the pheromone is 
protected from protease digestion in the absence of detergent 
(lane 3).  This  provides  evidence that a-factor is  localized 
within  a  membrane-sealed  vesicle with the orientation ex- 
pected for a transport vesicle. The fact that only 66% of the 
a-factor is protected in comparison to the protease untreated 
sample (Fig.  9,  lane  1) may be explained by some damage 
of vesicles caused by resuspension of the P3. With a smaller 
amount of proteinase K (0.2 mg/ml) in the presence of Triton 
X-100, 70% of the a-factor is degraded after 15 min and al- 
most all is degraded after 30-min incubation at 30°C (data 
not  shown).  This  shows  that  proteolysis  is  limited  by the 
amount of proteinase K  and not due to unspecific protease 
activity that could be released  by Triton X-100. 
Another line of evidence confirming the idea that a-factor 
is contained within a  vesicular compartment is supplied by 
floatation analysis of the P3 fraction on a Nycodenz gradient. 
In this experiment the $2  fraction was obtained after cen- 
trifugation of the lysate at 3,500 and 7,500 g, each for 5 mijn, 
in  order  to optimize  the  recovery of a-factor in  the  high 
speed pellet (P3). The density gradient was subjected to cen- 
trifugation at 100,000 g for 14-16 h to allow the vesicles to 
reach their equilibrium density, then was fractionated,  and 
the amount of 35S-a-factor, H+-ATPase, and protein in each 
fraction quantified. The results of one typical experiment are 
presented in Fig.  10. The a-factor is present in two peaks at 
densities of "~1.12 and 1.14 g/ml, respectively, both of which 
are clearly  resolved  from the bulk protein.  Moreover,  the 
distribution  of  a-factor  and  the  plasma  membrane  H ÷- 
ATPase, peaking predominately at a density of 1.16 g/ml, are 
clearly distinct,  supporting again the idea that the cx-factor 
is not associated  with the plasma membrane. 
Discussion 
Reduction of temperature and metabolic inhibitors have been 
used  extensively  to  arrest  membrane  transport  at  defined 
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sociated  with  P3 after uptake at 
15°C  is  protease  protected.  35S- 
a-factor uptake at 15°C and prep- 
aration  of  subcellular  fractions 
were carried out as described in 
the  legend  to Fig.  8.  The high- 
speed pellet (P3) was resuspended 
in 0.6 M  sorbitol buffer  and  in- 
cubated with  or without 0.5 mg/ 
ml proteinase  K in the presence 
or absence of 0.5% Triton X-100, 
as indicated,  at 30°C for 15 min. 
The reaction was stopped by chil- 
ling the samples  on ice and addition of 1 mM PMSE The samples 
were resolved  by SDS-PAGE on a  17.5% gel.  The amount of35S  - 
a-factor in each lane was quantified  by densitometric scanning of 
the fluorogram. The fluorogram was exposed  for 2 d at  -70°C. 
stages in the endocytic and exocytic pathways in mammalian 
cells  (reviewed  by Mellman  et al.,  1986;  Griffiths and Si- 
mons,  1986; Pfeffer and Rothman,  1987).  In this study we 
have examined the effect of low temperature and metabolic 
poisons on transport of the yeast pheromone c~-factor to the 
vacuole. There are several lines of evidence that are consis- 
tent with the notion that a-factor degradation takes place in 
the  vacuole.  First,  degradation  is  dependent  on  the PEP4 
gene  product,  proteinase  A.  This protease  is essential  for 
vacuolar zymogen activation,  so that  cells  carrying muta- 
tions in the PEP4 gene have a major defect in vacuolar hydro- 
lytic activity (Ammerer et al.,  1986; Wollford et al.,  1986). 
Although pep4 cells internalize a-factor as efficiently as wild- 
type cells, the majority of the pheromone remains intact. In 
agreement with this, a mutant that lacks a functional vacuole 
(endl) also does not degrade or-factor, although the phero- 
mone is internalized  normally (Duli6 and Riezman,  1989). 
Second,  analysis of the sedimentation  behavior of c~-factor 
from lysates of cells that have internalized the pheromone for 
30 min at 30°C show a nearly perfect codistribution of oe-fac- 
tor and the vacuolar marker CPY.  Even though the P1 frac- 
tion, where the majority of the a-factor and CPY are found, 
is  not a  pure  fraction,  we  show  here  that  at  least  plasma 
membrane  fractionates  differently.  Another  organelle  that 
should be found predominately in this fraction is the nucleus. 
However, we think it is very unlikely that the pheromone is 
associated with the nucleus, as the enzymes that are activated 
by the PEP4 gene product are not found there (Wiemken et 
al.,  1979; van Tuinen and Riezman,  1987).  Third,  an ele- 
vated pH of  the vacuolar system apparently slows down phero- 
mone degradation. This is similar to what has been observed 
in mammalian  cells,  using  lysosomotropic agents and car- 
boxylic ionophores  (reviewed by Mellman  et al.,  1986). 
Using c~-factor degradation as a marker for transport to the 
vacuole, we have established  conditions that allow u-factor 
uptake, but result in a  significantly reduced rate of delivery 
to the vacuole. At 19°C the rates of uptake and degradation 
are similarly  reduced  in comparison to 30°C.  However,  at 
15 and 10°C degradation is proportionally more delayed than 
uptake (Table I). Our data favor the hypothesis that this delay 
in degradation is due to a  kinetic block of transport to the 
vacuole, rather than to an inhibition  of vacuolar hydrolytic 
activity.  First,  a-factor that is taken up at  15°C for 20 min 
does  not  cofractionate  with  the  vacuolar  marker  CPY, 
whereas after internalization at 30°C for 30 min it does. Sec- 
ond,  when cells that have internalized  c~-factor for 15 min 
at  15°C are shifted to 30°C, the time required for degrada- 
tion products to appear is similar to when the uptake is car- 
ried out exclusively at 30°C.  If e-factor already resided  in 
the vacuole after uptake at  15°C,  one would not expect to 
find a  15-rain lag in degradation.  As or-factor degradation 
seems not to be limiting in our assay, these data suggest that 
the rate limiting step in the appearance of degradation prod- 
ucts, even at 30°C, is the transport of or-factor to the vacuole. 
This  is  consistent  with  results  obtained  with  mammalian 
cells, which show that fusion between endocytic vesicles and 
lysosomes in the perfused rat liver is the slowest step that oc- 
curs during the catabolism of asialoglycoprotein.  This step 
is blocked at temperatures below 20°C (Dunn et al.,  1980). 
A  similar  result was obtained by Marsh et al.  (1983),  who 
characterized the entry pathway of Semliki  Forest virus in 
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Figure 10. Floatation analysis of P3 on a density gradient.  The P3 
fraction containing the 35S-tx-factor  after uptake at  15°C was used 
for the floatation analysis and was prepared in the same way as de- 
scribed  in Fig. 8 with the exception that the second differential cen- 
trifugation  step  was  at  7,500  g  for 5  min.  The P3  fraction was 
resuspended  in 35 % Nycodenz, 1 ml was placed into a centrifuga- 
tion tube and overlaid with each 2.5 ml of four different Nycodenz 
dilutions  in  sorbitol  medium  as  described  in  Materials  and 
Methods.  The gradient was centrifuged  at  100,000 g for 14-16 h 
at 4°C and was collected  from the top. Aliquots  from each of the 
17 fractions were analyzed for 35S-a-factor (m), H  +- ATPase (o), 
protein  concentration  (A),  and  density  (<>) as  described  in 
Materials  and Methods.  Only 40% of protein applied  to the gra- 
dient  was recovered,  most likely due to the fact that a major part 
of the pellet formed during centrifugation  was not collected.  How- 
ever,  >95 % of the radioactivity was  recovered. 
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proteins from endosomes to lysosomes is also blocked at 
200C. The finding that endocytic traffic in yeast seems to be 
efficiently slowed down only at 15°C, whereas in mammalian 
cells it is reduced at 20°C, is not surprising,  because yeast cells 
normally grow at lower temperatures than mammalian cells. 
In conjunction with low temperature incubations, we made 
use  of the  metabolic  inhibitors  NaN3  and  NaF  to  block 
transport from a prevacuolar compartment(s) to the vacuole. 
Both treatments are necessary to completely block the trans- 
port from this compartment, since low temperature installs 
only a kinetic block. The effect of the metabolic inhibitors 
on a-factor transport is consistent with in vitro experiments 
that reconstitute parts of mammalian endocytic (Davey et al., 
1985;  Gruenberg and Howell,  1986;  Smythe et al.,  1989) 
and exocytic transport (Balch et al.,  1984).  These studies 
showed that budding and fusion of vesicles are dependent on 
ATP.  In our experiments we found that 5  mM  NaN3  and 
NaF were sufficient to block degradation in vivo and trans- 
port of a-factor to the vacuole, even at 30°C. It is unlikely 
that the metabolic poisons inhibit degradation by increasing 
the vacuolar pH and thereby inhibiting the vacuolar hydro- 
lytic enzyme activity. Brief treatment of cells with bafilomy- 
cin A~ results in an increase of vacuolar pH, which can be 
monitored by the lack of vacuolar labeling with quinacrine. 
However, bafilomycin A~  does not block a-factor degrada- 
tion in contrast to treatment with NaN3 and NaE This per- 
mits us to conclude that the lack of a-factor degradation, 
seen in the presence of metabolic inhibitors, is not solely due 
to an elevated vacuolar pH, but to a block in delivery to the 
vacuole.  The finding  that bafilomycin At  changed  the ki- 
netics of c~-factor degradation in comparison to control cells 
cannot be explained at the moment, but is currently being in- 
vestigated in more detail. 
Direct evidence that a-factor transport from the plasma 
membrane to the vacuole involves at least one intermediate 
compartment comes from analysis of the sedimentation be- 
havior of the pheromone internalized under various condi- 
tions. Pheromone that was incubated with cells under condi- 
tions where we predicted an association with either plasma 
membrane or vacuole does  in  fact cofractionate with  the 
plasma membrane H÷-ATPase and CPY,  respectively,  a-Fac- 
tor that is internalized at  15°C  under conditions where no 
degradation products can be detected, has a sedimentation 
behavior that is strikingly different from that of the vacuole 
or plasma membrane markers. The largest proportion of the 
a-factor is found in the  100,000-g pellet, but some of it is 
also associated with the 3,500-g pellet, the 10,000-g  pellet, 
and the 100,000-g supernatant. At the moment we can only 
speculate about the origin of the pheromone found in these 
fractions, a-Factor that is pelletable at 3,500 g could be as- 
sociated with the plasma membrane. After a 20-min incuba- 
tion at 15°C  ,x,20%  of pheromone is still  3ensitive to a pH 
1.2 wash (Fig.  1) and '~50-60%  of the plz,  sma membrane 
pellets at 3,500 g. By using the same type of calculation only 
a  minor amount of pheromone found in  the  10,000-  and 
100,000-g pellets could be derived from the plasma mem- 
brane. In addition, only very small quantities of pheromone 
present in these fractions could originate from the vacuole. 
Therefore, we conclude that most of the radioactivity sedi- 
menting into P2 and P3  originates from a-factor residing 
within the intermediate compartment(s). 
Floatation analysis of the 100,000-g fraction, obtained af- 
ter a-factor uptake at  15°C,  reveals that the pheromone is 
present in two peaks.  This demonstrates conclusively that 
the pheromone is associated with at least one membranous 
compartment that  is  distinct from the plasma  membrane. 
The  two  a-factor-containing  peaks  could  represent  two 
different compartments involved in transport to the vacuole. 
However, the possibility that they represent the same com- 
partment in an intact and damaged form cannot be excluded 
at this point. 
The existence of an intermediate, endocytic compartment 
in S. cerevisiae has previously been claimed by Makarow and 
Nevalainen  (1987)  using  commercially  available  FITC- 
dextran.  Subsequently, Preston et al.  (1987)  demonstrated 
that intracellular labeling under these conditions is due to 
low molecular weight impurities in the commercially avail- 
able FITC-dextran. Therefore, the labeling seen by Makarow 
and Nevalainen cannot be considered to be endocytic in ori- 
gin. Makarow (1985a) has also proposed that Semliki Forest 
virus and vesicular stomatitis virus, well-established endo- 
cytic markers in mammalian cells (Helenius et al.,  1980), 
are taken up by endocytosis into yeast spheroplasts. After in- 
ternalization and cell lysis three density gradient fractions 
were claimed to contain the viral proteins,  one of which 
coincided with  vacuolar markers,  one with  plasma  mem- 
brane markers, and one banded between the vacuolar and the 
plasma membrane markers. Makarow considered either or 
both of the latter fractions to represent intermediary com- 
partments operating in transport to the vacuole. However, 
the evidence that virus is delivered to the vacuole is not con- 
vincing. Approximately the same proportion of viral radio- 
activity and plasma membrane marker cofractionate with the 
vacuolar marker. This calls into question this interpretation 
and perhaps the use of these viruses as endocytic markers in 
yeast. 
If the intermediate compartment(s) that we propose is en- 
docytic in origin then one would expect the a-factor to re- 
side within this organelle(s). Evidence in support of this is 
provided by the finding that the pheromone present in P3 af- 
ter uptake at  15°C  is protease protected. High concentra- 
tions  of protease and  incubation at  30°C  for  15  min  are 
necessary to degrade all the a-factor in the presence of Tri- 
ton X-100 whereas in vitro the pure pheromone is more sen- 
sitive to protease (Singer, B., unpublished observation). We 
speculate that this might reflect a tight association of a-factor 
with  some  other  protein(s).  If the  pheromone  would  be 
freely diffusable within the vesicle, such high concentrations 
and temperatures would presumably not be necessary for 
degradation. Since a-factor is most likely taken up by recep- 
tor-mediated endocytosis, the a-factor receptor is certainly 
a good candidate for a protein to which the pheromone might 
be bound, a-Factor, because it is rather small, could be bur- 
ied by parts of the receptor, so that only after protease diges- 
tion of the receptor would a-factor become accessible to the 
protease. 
It still remains to be demonstrated that the a-factor recep- 
tor is internalized. The first hint, that the receptor is taken 
up by iigand-induced endocytosis, comes from studies by 
Jenness  and  Spatrick  (1986)  demonstrating  that  a-factor 
binding  activity disappears  from the  surface concomitant 
with pheromone uptake. Analysis of receptor truncation mu- 
tants  has  revealed that  COOH-terminal  sequences  of the 
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tion to regulate  receptor  internalization and adaptation to 
pheromone  by  phosphorylation  (Konopka  et  al.,  1988; 
Reneke et al.,  1988).  Recently,  Dietzel and Kurjan (1987) 
and Miyajima et al.  (1987) provided the first evidence for a 
receptor-coupled G-protein in yeast, that is involved in mat- 
ing.  The  G-protein  subunits  show  sequence  homology to 
mammalian receptor-coupled G-proteins. In addition to this 
similarity,  the u-factor receptor and some G-protein-coupled 
receptors like rhodopsin and the/3-adrenergic receptor share 
striking structural homology, in that they all contain seven 
transmembrane domains, and NH2-terminal  exoplasmic, and 
a COOH-terminal cytoplasmic domain. Evidence has accu- 
mulated that suggests that the/3-adrenergic receptor is inter- 
nalized (called sequestration)  (reviewed by Sibley et al., 1987). 
However, the mechanism of internalization and subsequent 
targeting of polytopic signal transduction receptors has not 
been clarified yet in any system.  One clue from yeast may 
come from work on clathrin-deficient mutants. They are still 
able to carry out o~-factor uptake, although it is reduced by 
50-65 % (Payne et al.,  1988). Besides the inherent difficulty 
to interpret this partial effect,  there is no reason to believe 
at the present time that clathrin is strictly required for recep- 
tor-mediated endocytosis, nor is there convincing evidence 
that polytopic signal transduction receptors are internalized 
via clathrin-coated pits. Since we are now in a position to iso- 
late and characterize the intermediate compartment(s) that is 
involved in transport of o~-factor to the vacuole, we hope to 
learn more soon about the molecular requirements of the en- 
docytic transport pathway in yeast. 
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